Published in:
Open Access
01-10-2020 | SARS-CoV-2 | Correspondence
Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology
Authors:
Nikolaus Deigendesch, Lara Sironi, Michael Kutza, Sven Wischnewski, Vidmante Fuchs, Jürgen Hench, Angela Frank, Ronny Nienhold, Kirsten D. Mertz, Gieri Cathomas, Matthias S. Matter, Martin Siegemund, Markus Tolnay, Lucas Schirmer, Anne-Katrin Pröbstel, Alexandar Tzankov, Stephan Frank
Published in:
Acta Neuropathologica
|
Issue 4/2020
Login to get access
Excerpt
Infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily lead to upper respiratory tract infection and its sequelae frequently dominate the clinical course of COVID-19 [
11,
25]. In addition to the lung, various other organs such as kidneys, gut, and heart can be affected [
13,
20,
25]. Initially less noticed, it is now well documented that patients with COVID-19 can clinically present with a variety of neurological symptoms ranging from anosmia and dysgeusia to headache, impaired consciousness, agitation, and corticospinal tract signs [
14]. Moreover, COVID-19 patient presentations with acute ischemic stroke, meningoencephalitis, hemorrhagic posterior reversible encephalopathy syndrome, acute disseminated encephalomyelitis (ADEM)-like pathology, as well as with diffuse leukoencephalopathy and microhemorrhages are on record [
13,
21,
22]. Despite this wide range of neurological affections, it has so far remained unclear whether the reported abnormalities are pathogenetically linked to SARS-CoV-2 or occur coincidentally or in association with critical illness. …